Abstract
Pancreaticobiliary maljunction (PBM) is a congenital anomaly in which the reciprocal reflux between pancreatic and bile juice occurs because the confluence of the pancreatic and bile ducts lies outside of the area of contractile influence of the sphincter of Oddi. The reflux of pancreatic juice into the bile duct and subsequent elevated pancreatic enzyme level in bile are usually recognized in PBM. Amylase is the most popular pancreatic enzyme for assessment in daily practice, and assessment of amylase level in bile is useful to definitively confirm the presence of PBM, and the mixture of pancreatic and bile juices may produce various physiological and pathological alterations. In PBM, the amylase level in bile in patients with biliary cancers has been reported to be higher than that with benign biliary diseases; however, the relationship between the amylase level in bile and development of biliary diseases has not been well documented. Recently, several studies have demonstrated that some patients with a normal morphological pancreaticobiliary junction have a high amylase level and biliary carcinoma. This suggests the possibility that pancreaticobiliary reflux can occur even in patients without PBM and result in the development of biliary carcinoma in the same manner as in patients with PBM.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Kamisawa T, Ando H, Suyama M, et al. Japanese clinical practice guidelines for pancreaticobiliary maljunction. J Gastroenterol. 2012;47:731–59.
Shimada K, Yanagisawa J, Nakayama F. Increased lysophosphatidylcholine and pancreatic enzyme content in bile of patients with anomalous pancreaticobiliary ductal junction. Hepatology. 1991;13:438–44.
Tuchida A, Itoi T. Carcinogenesis and chemoprevention of biliary tract cancer in pancreaticobiliary maljunction. World J Gastrointest Oncol. 2010;2:130–5.
Sugiyama Y, Kobori H, Hakamada K, et al. Altered bile composition in the gallbladder and common bile duct of patients with anomalous pancreaticobiliary ductal junction. World J Surg. 2000;24:17–21.
Fujimoto T, Ohtsuka T, Nakashima Y, et al. Elevated bile amylase level without pancreaticobiliary maljunction is a risk factor for gallbladder carcinoma. J Hepatobiliary Pancreat Sci. 2017;24:103–8.
Sai JK, Suyama M, Kubokawa Y, et al. Gallbladder carcinoma associated with pancreatobiliary reflux. World J Gastroenterol. 2006;12:6527–30.
Itokawa F, Itoi T, Nakamura K, et al. Assessment of occult pancreatobiliary reflux in patients with pancreaticobiliary disease by ERCP. J Gastroenterol. 2004;39:988–94.
Donaldson LA, Joffe SN, Mclntosh W, et al. Amylase activity in human bile. Gut. 1979;20:216–8.
Motosugi U, Ichikawa T, Araki T, et al. Secretin-stimulating MRCP in patients with pancreatobiliary maljunction and occult pancreatobiliary reflux: direct demonstration of pancreatobiliary reflux. Eur Radiol. 2007;17:2262–7.
Sakamoto H, Mutoh H, Ido K, et al. Intestinal metaplasia in gallbladder correlates with high amylase levels in bile in patients with a morphologically normal pancreaticobiliary duct. Hum Pathol. 2009;40:1762–7.
Ragot E, Mabrut JY. Ouaïssi, et al. Pancreaticobiliary Maljunctions in European patients with bile duct cysts: results of the multicenter study of the French Surgical Association (AFC). World J Surg. 2017;41:538–45.
Jeong IH, Jung YS, Kim H, et al. Amylase level in extrahepatic bile duct in adult patients with choledochal cyst plus anomalous pancreatico-biliary ductal union. World J Gastroenterol. 2005;11:1965–70.
Jung SM, Seo JM, Lee SK. The relationship between biliary amylase and the clinical features of choledochal cysts in pediatric patients. World J Surg. 2012;36:2098–101.
Kamisawa T, Suyama M, Fujita N, et al. Pancreatobiliary reflux and the length of a common channel. J Hepatobiliary Pancreat Sci. 2010;17:865–70.
Tashiro S, Imaizumi T, Ohkawa H, et al. Pancreaticobiliary maljunction: retrospective and nationwide survey in Japan. J Hepato-Biliary-Pancreat Surg. 2003;10:345–51.
Beltrán MA, Vracko J, Cumsille MA, et al. Occult pancreaticobiliary reflux in gallbladder cancer and benign gallbladder diseases. J Surg Oncol. 2007;96:26–31.
Horaguchi J, Fujita N, Kamisawa T, et al. Pancreatobiliary reflux in individuals with a normal pancreatobiliary junction: a prospective multicenter study. J Gastroenterol. 2014;49:875–81.
Adachi T, Tajima Y, Kuroki T, et al. Bile-reflux into the pancreatic ducts is associated with the development of intraductal papillary carcinoma in hamsters. J Surg Res. 2006;136:106–11.
Morine Y, Shimada M, Takamatsu H, et al. Clinical features of pancreaticobiliary maljunction: update analysis of 2nd Japan-nationwide survey. J Hepatobiliary Pancreat Sci. 2013;20:472–80.
Itoi T, Tsuchida A, Itokawa F, et al. Histologic and genetic analysis of the gallbladder in patients with occult pancreatobiliary reflux. Int J Mol Med. 2005;15:425–30.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Fujimoto, T., Ohtsuka, T., Nakamura, M. (2018). Elevation of Pancreatic Enzymes in Bile of PBM. In: Kamisawa, T., Ando, H. (eds) Pancreaticobiliary Maljunction and Congenital Biliary Dilatation. Springer, Singapore. https://doi.org/10.1007/978-981-10-8654-0_17
Download citation
DOI: https://doi.org/10.1007/978-981-10-8654-0_17
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-10-8653-3
Online ISBN: 978-981-10-8654-0
eBook Packages: MedicineMedicine (R0)